Literature DB >> 23276608

Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning.

Philipp Singer1, Catherine J Wei, Jiang-Fan Chen, Detlev Boison, Benjamin K Yee.   

Abstract

Following early clinical leads, the adenosine A(2A)R receptor (A(2A)R) has continued to attract attention as a potential novel target for treating schizophrenia, especially against the negative and cognitive symptoms of the disease because of A(2A)R's unique modulatory action over glutamatergic in addition to dopaminergic signaling. Through (i) the antagonistic interaction with the dopamine D(2) receptor, and (ii) the regulation of glutamate release and N-methyl-d-aspartate receptor function, striatal A(2A)R is ideally positioned to fine-tune the dopamine-glutamate balance, the disturbance of which is implicated in the pathophysiology of schizophrenia. However, the precise function of striatal A(2A)Rs in the regulation of schizophrenia-relevant behavior is poorly understood. Here, we tested the impact of conditional striatum-specific A(2A)R knockout (st-A(2A)R-KO) on latent inhibition (LI) and prepulse inhibition (PPI) - behavior that is tightly regulated by striatal dopamine and glutamate. These are two common cross-species translational tests for the assessment of selective attention and sensorimotor gating deficits reported in schizophrenia patients; and enhanced performance in these tests is associated with antipsychotic drug action. We found that neither LI nor PPI was significantly affected in st-A(2A)R-KO mice, although a deficit in active avoidance learning was identified in these animals. The latter phenotype, however, was not replicated in another form of aversive conditioning - namely, conditioned taste aversion. Hence, the present study shows that neither learned inattention (as measured by LI) nor sensory gating (as indexed by PPI) requires the integrity of striatal A(2A)Rs - a finding that may undermine the hypothesized importance of A(2A)R in the genesis and/or treatment of schizophrenia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276608      PMCID: PMC3566338          DOI: 10.1016/j.bbr.2012.12.024

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  67 in total

1.  Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia.

Authors:  S H Kafka; R Corbett
Journal:  Eur J Pharmacol       Date:  1996-01-11       Impact factor: 4.432

2.  NMDA receptor and schizophrenia: a brief history.

Authors:  Joseph T Coyle
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

3.  Differential performance of acute and chronic schizophrenics in a latent inhibition task.

Authors:  I Baruch; D R Hemsley; J A Gray
Journal:  J Nerv Ment Dis       Date:  1988-10       Impact factor: 2.254

4.  Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice.

Authors:  Anil Kachroo; Lianna R Orlando; David K Grandy; Jiang-Fan Chen; Anne B Young; Michael A Schwarzschild
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

Review 5.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

6.  Adenosine agonists reduce conditioned avoidance responding in the rat.

Authors:  G E Martin; D J Rossi; M F Jarvis
Journal:  Pharmacol Biochem Behav       Date:  1993-08       Impact factor: 3.533

7.  A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs.

Authors:  Hai-Ying Shen; Joana E Coelho; Nobuhisa Ohtsuka; Paula M Canas; Yuan-Ji Day; Qing-Yuan Huang; Nelson Rebola; Liqun Yu; Detlev Boison; Rodrigo A Cunha; Joel Linden; Joe Z Tsien; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

8.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

Authors:  N S Gray; L S Pilowsky; J A Gray; R W Kerwin
Journal:  Schizophr Res       Date:  1995-09       Impact factor: 4.939

9.  Twenty-five years of glutamate in schizophrenia: are we there yet?

Authors:  Daniel C Javitt
Journal:  Schizophr Bull       Date:  2012-09       Impact factor: 9.306

10.  Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction.

Authors:  Benjamin K Yee; Joram Feldon
Journal:  Behav Brain Res       Date:  2008-12-09       Impact factor: 3.332

View more
  7 in total

1.  MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348.

Authors:  Steven M Grauer; Robert Hodgson; Lynn A Hyde
Journal:  Psychopharmacology (Berl)       Date:  2013-10-23       Impact factor: 4.530

Review 2.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

Review 3.  Purinergic signaling and energy homeostasis in psychiatric disorders.

Authors:  D Lindberg; D Shan; J Ayers-Ringler; A Oliveros; J Benitez; M Prieto; R McCullumsmith; D-S Choi
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

4.  Optogenetic Activation of Adenosine A2A Receptor Signaling in the Dorsomedial Striatopallidal Neurons Suppresses Goal-Directed Behavior.

Authors:  Yan Li; Yan He; Mozi Chen; Zhilan Pu; Li Chen; Ping Li; Bo Li; Haiyan Li; Zhi-Li Huang; Zhihui Li; Jiang-Fan Chen
Journal:  Neuropsychopharmacology       Date:  2015-07-28       Impact factor: 7.853

Review 5.  Contribution of emotional and motivational neurocircuitry to cue-signaled active avoidance learning.

Authors:  Anton Ilango; Jason Shumake; Wolfram Wetzel; Frank W Ohl
Journal:  Front Behav Neurosci       Date:  2014-10-27       Impact factor: 3.558

Review 6.  Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.

Authors:  Vladimir S Naumenko; Evgeni Ponimaskin
Journal:  Neural Plast       Date:  2018-04-03       Impact factor: 3.599

Review 7.  Human latent inhibition: Problems with the stimulus exposure effect.

Authors:  N C Byrom; R M Msetfi; R A Murphy
Journal:  Psychon Bull Rev       Date:  2018-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.